203 related articles for article (PubMed ID: 32913122)
21. Simvastatin exerts anticancer effects in osteosarcoma cell lines via geranylgeranylation and c-Jun activation.
Kany S; Woschek M; Kneip N; Sturm R; Kalbitz M; Hanschen M; Relja B
Int J Oncol; 2018 Apr; 52(4):1285-1294. PubMed ID: 29532878
[TBL] [Abstract][Full Text] [Related]
22. Simvastatin-mediated enhancement of long-term potentiation is driven by farnesyl-pyrophosphate depletion and inhibition of farnesylation.
Mans RA; McMahon LL; Li L
Neuroscience; 2012 Jan; 202():1-9. PubMed ID: 22192838
[TBL] [Abstract][Full Text] [Related]
23. The analytical determination of isoprenoid intermediates from the mevalonate pathway.
Nürenberg G; Volmer DA
Anal Bioanal Chem; 2012 Jan; 402(2):671-85. PubMed ID: 21789486
[TBL] [Abstract][Full Text] [Related]
24. The UFM1 system regulates ER-phagy through the ufmylation of CYB5R3.
Ishimura R; El-Gowily AH; Noshiro D; Komatsu-Hirota S; Ono Y; Shindo M; Hatta T; Abe M; Uemura T; Lee-Okada HC; Mohamed TM; Yokomizo T; Ueno T; Sakimura K; Natsume T; Sorimachi H; Inada T; Waguri S; Noda NN; Komatsu M
Nat Commun; 2022 Dec; 13(1):7857. PubMed ID: 36543799
[TBL] [Abstract][Full Text] [Related]
25. Simvastatin reduces lipoprotein-associated phospholipase A2 in lipopolysaccharide-stimulated human monocyte-derived macrophages through inhibition of the mevalonate-geranylgeranyl pyrophosphate-RhoA-p38 mitogen-activated protein kinase pathway.
Song JX; Ren JY; Chen H
J Cardiovasc Pharmacol; 2011 Feb; 57(2):213-22. PubMed ID: 21052011
[TBL] [Abstract][Full Text] [Related]
26. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation.
Lee MH; Cho YS; Han YM
Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088
[TBL] [Abstract][Full Text] [Related]
27. Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.
Tanaka T; Tatsuno I; Uchida D; Moroo I; Morio H; Nakamura S; Noguchi Y; Yasuda T; Kitagawa M; Saito Y; Hirai A
J Neurosci; 2000 Apr; 20(8):2852-9. PubMed ID: 10751437
[TBL] [Abstract][Full Text] [Related]
28. Impact of statins on cellular respiration and de-differentiation of myofibroblasts in human failing hearts.
Emelyanova L; Sra A; Schmuck EG; Raval AN; Downey FX; Jahangir A; Rizvi F; Ross GR
ESC Heart Fail; 2019 Oct; 6(5):1027-1040. PubMed ID: 31520523
[TBL] [Abstract][Full Text] [Related]
29. Conditional loss of geranylgeranyl diphosphate synthase alleviates acute obstructive cholestatic liver injury by regulating hepatic bile acid metabolism.
Jia WJ; Tang QL; Jiang S; Sun SQ; Xue B; Qiu YD; Li CJ; Mao L
FEBS J; 2020 Aug; 287(15):3328-3345. PubMed ID: 31905247
[TBL] [Abstract][Full Text] [Related]
30. Brain isoprenoids farnesyl pyrophosphate and geranylgeranyl pyrophosphate are increased in aged mice.
Hooff GP; Wood WG; Kim JH; Igbavboa U; Ong WY; Muller WE; Eckert GP
Mol Neurobiol; 2012 Aug; 46(1):179-85. PubMed ID: 22692983
[TBL] [Abstract][Full Text] [Related]
31. Isoprenoid pyrophosphate analogues regulate expression of Ras-related proteins.
Holstein SA; Wohlford-Lenane CL; Wiemer DF; Hohl RJ
Biochemistry; 2003 Apr; 42(15):4384-91. PubMed ID: 12693933
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients.
Eckert GP; Hooff GP; Strandjord DM; Igbavboa U; Volmer DA; Müller WE; Wood WG
Neurobiol Dis; 2009 Aug; 35(2):251-7. PubMed ID: 19464372
[TBL] [Abstract][Full Text] [Related]
33. Regulation of fatty acid synthesis by farnesyl pyrophosphate.
Murthy S; Tong H; Hohl RJ
J Biol Chem; 2005 Dec; 280(51):41793-804. PubMed ID: 16221687
[TBL] [Abstract][Full Text] [Related]
34. Independent pathways in the modulation of osteoclastic resorption by intermediates of the mevalonate biosynthetic pathway: the role of the retinoic acid receptor.
van Beek E; Löwik C; Karperien M; Papapoulos S
Bone; 2006 Feb; 38(2):167-71. PubMed ID: 16165408
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the isoprenoid biosynthesis pathway; detection of intermediates by UPLC-MS/MS.
Henneman L; van Cruchten AG; Kulik W; Waterham HR
Biochim Biophys Acta; 2011 Apr; 1811(4):227-33. PubMed ID: 21237288
[TBL] [Abstract][Full Text] [Related]
36. Loss of smooth muscle CYB5R3 amplifies angiotensin II-induced hypertension by increasing sGC heme oxidation.
Durgin BG; Hahn SA; Schmidt HM; Miller MP; Hafeez N; Mathar I; Freitag D; Sandner P; Straub AC
JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31487266
[TBL] [Abstract][Full Text] [Related]
37. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products.
Liang YJ; Shyu KG; Wang BW; Lai LP
Cardiology; 2008; 110(3):182-90. PubMed ID: 18057884
[TBL] [Abstract][Full Text] [Related]
38. Sex-specific metabolic adaptations in transgenic mice overexpressing cytochrome b
Sánchez-Mendoza LM; Pérez-Sánchez C; Rodríguez-López S; López-Pedrera C; Calvo-Rubio M; de Cabo R; Burón MI; González-Reyes JA; Villalba JM
Free Radic Biol Med; 2023 Oct; 207():144-160. PubMed ID: 37463636
[TBL] [Abstract][Full Text] [Related]
39. External mitochondrial NADH-dependent reductase of redox cyclers: VDAC1 or Cyb5R3?
Nikiforova AB; Saris NE; Kruglov AG
Free Radic Biol Med; 2014 Sep; 74():74-84. PubMed ID: 24945955
[TBL] [Abstract][Full Text] [Related]
40. Functional characterization of the atypical integral membrane lipid phosphatase PDP1/PPAPDC2 identifies a pathway for interconversion of isoprenols and isoprenoid phosphates in mammalian cells.
Miriyala S; Subramanian T; Panchatcharam M; Ren H; McDermott MI; Sunkara M; Drennan T; Smyth SS; Spielmann HP; Morris AJ
J Biol Chem; 2010 Apr; 285(18):13918-29. PubMed ID: 20110354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]